Dr. Elizabeth C. Riley, MD

Dr. Riley practices at UofL Health - UofL Hospital in Louisville, Kentucky, part of UofL Health.

Dr. Riley's NPI, 1235202540, was assigned on November 16, 2006. Dr. Riley graduated from University of Louisville School of Medicine in 2002. Dr. Riley holds Kentucky license 43332.

Dr. Riley's primary practice is UofL Health - UofL Hospital, at 530 South Jackson Street, Louisville, KY 40202 in Jefferson County. The practice phone is (502) 562-3000.

Dr. Riley's primary practice is UofL Health - UofL Hospital in Louisville, Kentucky, part of UofL Health. Dr. Riley is also affiliated with Norton Hospital. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. Riley to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Riley practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Riley's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Riley's licenses on file in 2 states: Kentucky and Massachusetts.

CMS data shows 746 Medicare services from Dr. Riley across 5 procedure codes in 2024, for 249 Medicare patients. Medicare paid $46,939 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 249 Medicare patients who saw Dr. Riley in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have cancer, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Riley's median patient age at 70, with 98% women.

In 2024, Dr. Riley wrote 1,115 Medicare Part D claims for 203 patients. 85% of them were for generic drugs. CMS names the drug for 1,010 of them, across 27 drugs with 11 or more claims each, at $1,814,496 in total drug cost. In 2023, CMS named 821 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Riley for performance year 2024, reported as part of a group. Dr. Riley accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 30 papers to Dr. Riley, published from 2012 to 2024. 2017 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Mastectomy, Segmental and Breast. Dr. Riley has published most often in Int J Radiat Oncol Biol Phys. Dr. Riley's most frequent co-authors are Anthony E. Dragun, MD, Kelly M. McMasters, MD and Amy Riddell Quillo, MD.

Dmand AI links Dr. Riley to 6 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Blushing.

CMS Open Payments shows 310 general payments to Dr. Riley from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,461. It also lists 2 research payments totaling $20,650 in 2020.

Dr. Riley graduated from University of Louisville School of Medicine in 2002.